Minimally invasive surgery for resectable colorectal cancer with liver metastases: a prospective study
10.3760/cma.j.issn.1007-8118.2012.11.010
- VernacularTitle:可切除结直肠癌伴肝转移的微创手术治疗模式探索:前瞻性研究
- Author:
Hongwei YAO
;
Dianrong XIU
;
Wei FU
;
Jiong YUAN
;
Dechen WANG
;
Bin JIANG
;
Chaolai MA
;
Chunhui YUAN
;
Tao SUN
;
Liwen MA
;
Baoshan CAO
;
Jianyu LIU
;
Ming CHEN
;
Wen CHEN
;
Shi TAN
;
Yonghui HUANG
;
Li ZHANG
;
Xueying SHI
- Publication Type:Journal Article
- Keywords:
Colorectal cancer with liver metastases;
Resectability;
Minimally invasive surgery
- From:
Chinese Journal of Hepatobiliary Surgery
2012;(11):841-845
- CountryChina
- Language:Chinese
-
Abstract:
Objective To prospective study the use of minimally invasive surgery (MIS) for colorectal cancer with liver metastases (CRCLM) and to analyze the safety and survival outcomes.Methods 31 patients with resectable CRCLM were enrolled into this study from January 2009 to August 2011.Synchronous or metachronous liver metastases were diagnosed in 26 and 5 patients,respectively.The treatment strategy was discussed and decided by a multi disciplinary team which consisted of experienced colorectal surgeons,hepatic surgeons,medical oncologists,radiologists,and pathologists.Treatment included the use of neoadjuvant chemotherapy,one or two-staged surgery,and suitability to use laparoscopic surg(e)ry.Results Coloproctectomy and partial hepatectomy were carried out in all these patients,and every patient received at least one laparoscopic procedure.The operations in cluded: laparoscopic coloproctectomy plus hepatectomy (n=10),laparoscopic coloproctectomy only (n 18) and laparoscopic partial hepatcctomy only (n=3).One-staged coloproctectomy and hepatectomy were performed in 19 patients who presented with synchronous CRCLM.Colorectal and hepatic specific complications,such as anastomotic leak,liver failure,biliary leak,abdominal infection and abdominal bleeding,were not detected in these pati(e)nts.Neoadjuvant chemotherapy was used in 12 patients.Adjuvant chemotherapy was given to every patient.At a mean follow-up of 23.3 months from the diagnosis of liver metastases,the overall survival and disease-free survival were 87.1％ and 71.0％,respectively.Conclusions MIS for resectable CRCLM in carefully selected patients was safe and feasible.A one staged laparoscopic coloproctectomy and partial hepatectomy was possible.The short-middle oncologic outcomes were acceptable,but the long-term survival was still not clear.
